4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-104481
General Counsel and Secretary sold 2,800 shares at $52.80 ($147,840)
- General Counsel and Secretary acquired 5,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KASINGER JAMES R. · General Counsel and Secretary
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-10 | Exercise or conversion : show line 1 in the form | +5,500 | 90,615 | D | ||
| 2026-03-11 | Sale : show line 2 in the form | −2,800 | $52.80 | $147,840 | 87,815 | D |
| Open-market sales · 2,800 sh · avg $52.80 · $147,840 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-10 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −5,500 | 5,500 | D |
Loading xslF345X05/ownership.xml…